Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 1
1995 1
2007 1
2010 1
2011 2
2012 1
2014 2
2015 1
2016 1
2017 1
2018 1
2019 2
2020 1
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Ovarian Undifferentiated Sarcoma"
Page 1
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, Scally CP, Feig BW, Hunt KK, Roland CL, Guadagnolo A, Bishop AJ, Lazar AJ, Slopis JM, McCutcheon IE, Torres KE. Landry JP, et al. JAMA Netw Open. 2021 Mar 1;4(3):e210945. doi: 10.1001/jamanetworkopen.2021.0945. JAMA Netw Open. 2021. PMID: 33734413 Free PMC article.
Among patients with NF1, significantly lower 5-year DSS rates were found among those with undifferentiated pleomorphic sarcoma (1 of 5 patients [20.0%]), HGG (8 of 34 patients [23.1%]), MPNST (72 of 228 patients [31.6%]), ovarian carcinoma (4 of 7 patients [5 …
Among patients with NF1, significantly lower 5-year DSS rates were found among those with undifferentiated pleomorphic sarcoma …
Mesonephric-like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas.
Mirkovic J, Olkhov-Mitsel E, Amemiya Y, Al-Hussaini M, Nofech-Mozes S, Djordjevic B, Kupets R, Seth A, McCluggage WG. Mirkovic J, et al. Histopathology. 2023 Jun;82(7):978-990. doi: 10.1111/his.14892. Epub 2023 Mar 31. Histopathology. 2023. PMID: 36860193
AIMS: To report novel observations in five mesonephric-like adenocarcinomas (MLAs) of the female genital tract. ...CONCLUSIONS: Our observations provide additional evidence that MLAs have a Mullerian origin and characterise mesonephric-like carcinosarcomas in which …
AIMS: To report novel observations in five mesonephric-like adenocarcinomas (MLAs) of the female genital tract. ...CONCLUSIONS: Our …
Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations.
Oliva E. Oliva E. Int J Gynecol Pathol. 2014 Jul;33(4):374-84. doi: 10.1097/PGP.0000000000000141. Int J Gynecol Pathol. 2014. PMID: 24901397 Review.
An enigmatic category of uterine mesenchymal neoplasms, often densely cellular, are those descriptively referred to as "uterine tumors resembling ovarian sex cord tumors." Their spectrum is briefly noted as is their crucial distinction from stromal sarcoma with sex …
An enigmatic category of uterine mesenchymal neoplasms, often densely cellular, are those descriptively referred to as "uterine tumors resem …
Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.
Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA. Tafe LJ, et al. Mod Pathol. 2010 Jun;23(6):781-9. doi: 10.1038/modpathol.2010.41. Epub 2010 Mar 19. Mod Pathol. 2010. PMID: 20305618 Free article.
They are important to recognize as they have been shown to be clinically aggressive. We identified 32 carcinomas with undifferentiated components as defined by Silva and co-workers, 26 endometrial and 6 of ovarian origin. The patient age ranged from 21 to 76 years ( …
They are important to recognize as they have been shown to be clinically aggressive. We identified 32 carcinomas with undifferentiated …
Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.
Kang EY, Tessier-Cloutier B, Duggan MA, Stewart CJR, Lee CH, Köbel M. Kang EY, et al. Histopathology. 2021 Aug;79(2):160-167. doi: 10.1111/his.14333. Epub 2021 Jun 2. Histopathology. 2021. PMID: 33432679
METHODS AND RESULTS: We evaluated 1849 tumours that included 748 endometrial carcinomas, 101 uterine carcinosarcomas/adenosarcomas, 64 uterine sarcomas, 221 cervical carcinomas and 715 ovarian carcinomas/borderline tumours by tissue microarrays (TMA). We observed …
METHODS AND RESULTS: We evaluated 1849 tumours that included 748 endometrial carcinomas, 101 uterine carcinosarcomas/adenosarcomas, 64 uteri …
Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas.
Schaefer IM, Agaimy A, Fletcher CD, Hornick JL. Schaefer IM, et al. Mod Pathol. 2017 Apr;30(4):539-548. doi: 10.1038/modpathol.2016.230. Epub 2017 Jan 13. Mod Pathol. 2017. PMID: 28084340 Free article.
Membranous expression of claudin-4 (5% of cells) was observed in all biphasic synovial sarcomas (epithelial component only), all ovarian clear cell carcinomas, and 16 (80%) SWI/SNF complex-deficient undifferentiated carcinomas. ...The lack of claudin-4 …
Membranous expression of claudin-4 (5% of cells) was observed in all biphasic synovial sarcomas (epithelial component only), a …
SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
Kolin DL, Dong F, Baltay M, Lindeman N, MacConaill L, Nucci MR, Crum CP, Howitt BE. Kolin DL, et al. Mod Pathol. 2018 Sep;31(9):1442-1456. doi: 10.1038/s41379-018-0049-z. Epub 2018 Apr 26. Mod Pathol. 2018. PMID: 29700418 Free article.
These tumors were uniformly aggressive; all patients died of disease (median survival 7 months, range 1-43 months). We propose this entity be called "SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus)", a term which describes …
These tumors were uniformly aggressive; all patients died of disease (median survival 7 months, range 1-43 months). We propose this entity b …
Endometrial stromal sarcoma: clinicopathological and immunophenotype study of 18 cases.
Vera AA, Guadarrama MB. Vera AA, et al. Ann Diagn Pathol. 2011 Oct;15(5):312-7. doi: 10.1016/j.anndiagpath.2011.01.008. Epub 2011 Jun 8. Ann Diagn Pathol. 2011. PMID: 21652246
The objective of this article was to know the frequency and the clinical, morphologic, and immunophenotype characteristics of the endometrial stromal sarcoma (ESS). We reviewed the cases of ESS observed from 2002 to 2008 at the Pathology Unit of the General Hospital …
The objective of this article was to know the frequency and the clinical, morphologic, and immunophenotype characteristics of the endometria …
Primary synovial sarcoma of the ovary and Fallopian tube - case report and review of the literature.
Lenz J, Chvátal R, Fiala L, Kavka M. Lenz J, et al. Ceska Gynekol. 2019 Spring;84(3):212-215. Ceska Gynekol. 2019. PMID: 31324112 Review. English.
OBJECTIVE: Case description of advanced biphasic synovial sarcoma in the tubo-ovarian area. DESIGN: Case report. SETTING: Department of Pathology, Znojmo Hospital. METHODS: Own observation, review of the literature. CONCLUSION: The diagnosis of synovial sa …
OBJECTIVE: Case description of advanced biphasic synovial sarcoma in the tubo-ovarian area. DESIGN: Case report. SETTING: Depa …
HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy.
Rottmann D, Snir OL, Wu X, Wong S, Hui P, Santin AD, Buza N. Rottmann D, et al. Mod Pathol. 2020 Jan;33(1):118-127. doi: 10.1038/s41379-019-0358-x. Epub 2019 Sep 2. Mod Pathol. 2020. PMID: 31477811 Free article.
We aimed to systematically evaluate the characteristics of HER2 expression/amplification in gynecologic carcinosarcomas using standardized staining methods and scoring criteria. Tumors from 80 patients (65 uterine, 15 tubo-ovarian) were included, containing a serous (60%), …
We aimed to systematically evaluate the characteristics of HER2 expression/amplification in gynecologic carcinosarcomas using standardized s …
20 results